Rapid coronavirus test used by White House misses nearly half of positive cases [View all]
A rapid coronavirus diagnostic test manufactured by Abbott may miss nearly half of all positive infections, according to a pre-published study from New York University.
The analysis of Abbott's ID NOW system, which has not been peer-reviewed, found the test to be "unacceptable" in a clinical setting.
But Abbott said it's not clear if the researchers used the samples correctly. A spokesperson said the company's own rate of false negatives that it has shared with the Food and Drug Administration (FDA) is .02 percent.
"In communications with the users of the test, it is performing as expected," Darcy Ross said in a statement to The Hill. "ID NOW is an important tool that delivers information where its needed most taking the fight to the frontlines so that public health officials and healthcare providers can make critical decisions."
https://thehill.com/policy/healthcare/497661-abbotts-rapid-coronavirus-test-misses-nearly-half-of-positive-cases-study